Vanderbilt University Medical Center: Drug Shows Safety, Efficacy for Precancerous Stomach Lesions
June 18, 2025
June 18, 2025
NASHVILLE, Tennessee, June 18 (TNSjou) -- Vanderbilt University Medical Center issued the following news release:
* * *
Drug shows safety, efficacy for precancerous stomach lesions
The drug also showed promise that it could be the first therapeutic intervention against precancerous lesions in the stomach.
*
An early-stage clinical trial, supported by the Department of Defense, has demonstrated that the targeted cancer drug trametin . . .
* * *
Drug shows safety, efficacy for precancerous stomach lesions
The drug also showed promise that it could be the first therapeutic intervention against precancerous lesions in the stomach.
*
An early-stage clinical trial, supported by the Department of Defense, has demonstrated that the targeted cancer drug trametin . . .